FIELD: medicine.
SUBSTANCE: invention represents a therapeutic agent for oral cleaning in individuals suffering xerostomia, possessing antiseptic action and presented as spray, gel and mouthwash, containing a drug, differing by the fact that the drug contains hypromellose, boric acid and a flavour specified in a group: tea tree oil, menthol oil, eucalyptus oil and a consistency base in the following relations, g per 1ml of mixture: hypromellose 0.00001-0.5; boric acid 0.00001-0.5; flavour 0.00001-0.5; consistency base - the rest.
EFFECT: improving the properties of the agent.
2 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING INDIVIDUALS SUFFERING XEROSTOMIA | 2013 |
|
RU2538699C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
| ANTISEPTIC AND ANALGESIC THERAPEUTIC AGENT IN FORM OF GEL FOR PROCESSING AND LUBRICATING CATHETERS USED IN EXAMINING AND TREATING UROGENITAL SYSTEM | 2013 |
|
RU2540921C1 |
| PHARMACEUTICAL COMPOSITION FOR IMMEDIATE TREATMENT OF BURNS OF VARIOUS ORIGINS, AREA AND DEPTH IN FORM OF SPRAY, GEL AND AEROSOL | 2014 |
|
RU2545798C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING TROPHIC ULCERS AND PERSISTENT WOUNDS OF VARIOUS ORIGINS IN FORM OF OINTMENT | 2013 |
|
RU2539383C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561048C1 |
| CYTOKINE-CONTAINING MEDICATION, POSSESSING ANTIVIRAL, ANTIMICROBIAL, IMMUNOMODULATING AND ANTI-INFLAMMATORY ACTION FOR PREVENTION AND TREATMENT OF INFECTION DISEASES | 2013 |
|
RU2554495C2 |
| THERAPEUTIC AGENT IN FORM OF GEL FOR TREATING HERPETIC INFECTION MANIFESTATIONS IN PATIENTS WITH BURNS AND COLD INJURIES | 2013 |
|
RU2544163C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECOSIS, POSSESSING ANTIPARASITIC, ANTIBACTERIAL, ANTIVIRAL, IMMUNOMODULATORY ACTION | 2013 |
|
RU2538710C1 |
